Bausch + Lomb to present new AAO data on enVista Aspire, IC-8 Apthera IOLs and dry eye drugs Xiidra, Miebo
BLCO•Bausch + Lomb said it will present new clinical study data at the AAO annual meeting in New Orleans on Oct. 9-12. The studies cover eye procedures, intraocular lenses and dry-eye treatments.
1. Studies at AAO meeting
The planned posters cover cataract and glaucoma procedures, including outcomes suggesting stable vision with fewer medications following a MIGS approach. Other studies assess real-world visual and refractive performance of premium intraocular lenses, provider-identified responder profiles for Xiidra, and Miebo use around contact lens wear.
Related News
BlackRock report shows 68% of Canadian workplace savers worry about outliving retirement savings
BLK•
Boost Run signs Cohere GPU infrastructure deal worth about $525.6 million over five years
BRUN•
